The Orphan Drug Market: Growth Opportunities and Competitive Landscape in 2026
A rapidly maturing market, new legislative tailwinds, and a wave of next-generation modalities are reshaping what it means to compete — and win — in rare disease therapeutics.
READ MORE
Adaptive Trial Design Strategies for Small Patient Populations
How biotech companies can overcome the unique statistical and operational challenges of rare disease clinical trials through innovative adaptive methodologies.
READ MORE
